PJSC Pharmstandard (LSE: PHST IL, ÌÎÅÕ: PHST RU) (hereinafter the “Company” or “Pharmstandard”) announces the receipt of a mandatory tender offer to acquire ordinary shares of the Company. 
On June 22, 2016 the Company received from Augment Investments Limited, its controlling shareholder, a Russian law governed mandatory tender offer (the “Offer”) to acquire for cash ordinary shares of the Company from the remaining shareholders at a purchase price of RUB 1,028 per ordinary share.
The Offer is made in accordance with Article 84.2 of the Federal Law of the Russian Federation ¹ 208-FZ On Joint Stock Companies due to the fact that Augment Investments Limited together with its affiliate, OJSC Pharmstandard-Leksredstva, controls 86,11% of ordinary shares of the Company.
The Board of Directors meeting to review the Offer is scheduled for June 27, 2016.